Cargando…
Antitumor effects of valdecoxib on hypopharyngeal squamous carcinoma cells
The antitumoral effects of valdecoxib (Val), an United States Food and Drug Administration-approved anti-inflammatory drug that was withdrawn due to the side effects of increased risk of cardiovascular adverse events, were investigated in hypopharyngeal squamous cell carcinoma cells by performing a...
Autores principales: | Trang, Nguyen Thi Kieu, Yoo, Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614398/ https://www.ncbi.nlm.nih.gov/pubmed/36302619 http://dx.doi.org/10.4196/kjpp.2022.26.6.439 |
Ejemplares similares
-
The quest for targeted delivery in colon cancer: mucoadhesive
valdecoxib microspheres
por: Thakral, Naveen K, et al.
Publicado: (2011) -
Endoscopic Resection of Hypopharyngeal Squamous Cell Carcinoma
por: Bok, Gene Hyun, et al.
Publicado: (2013) -
Pulmonary Embolism in a Woman Taking Oral Contraceptives and Valdecoxib
por: Westgate, Elizabeth J, et al.
Publicado: (2005) -
Predictors of Thyroid Gland Involvement in Hypopharyngeal Squamous Cell Carcinoma
por: Chang, Jae Won, et al.
Publicado: (2015) -
Effects of Dexmedetomidine on the Pharmacokinetics of Parecoxib and Its Metabolite Valdecoxib in Beagles by UPLC-MS/MS
por: Hu, Jie, et al.
Publicado: (2020)